Defeating Asthma Series uncovers New Hope for Asthma Management In this second interview with Martin J Blaser MD, Director of the Center for Advanced Biotechnology and Medicine at Rutgers Biomedical and Health Sciences and the Henry Rutgers Chair of the…
Asthma and the Missing Microbes – Martin J Blaser MD Interview
Defeating Asthma Series uncovers New Hope for Asthma Management In this interview with Martin J Blaser MD, Director of the Center for Advanced Biotechnology and Medicine at Rutgers Biomedical and Health Sciences and the Henry Rutgers Chair of the Human…
Asthma and the Microbiome – Rodney Dietert PhD Interview
Defeating Asthma Series uncovers New Hope for Asthma Management In this interview with Rodney Dietert, PhD Cornell University Professor Emeritus, Health Scientist Head of Translational Science + Education for SEED and the Author of the Human Super-Organism How the Microbiome…
New Hope for Asthma Management – The Microbiome Podcast Series
New Hope for Asthma Management – World Asthma Foundation Announces The Microbiome Podcast Series Our understanding of Asthma and the way we treat it may soon be radically different from what currently exists, due to new research on the human…
Asthma and COVID-19 Update Study on Risk
Asthma does not appear to increase the risk or influence its severity, according to University study Whats new Rutgers researchers say further study is needed but those with the chronic respiratory disease don’t appear to be at a higher risk…
Why Cell Biology of Asthma Matters
Cell types responsible for the major pathology in asthma: 1. Epithelial cells – initiate airway inflammation mucus, and 2. Smooth muscle cells – contract excessively to cause airway narrowing. The clinical manifestations of asthma are caused by obstruction of the…
Aspirin Exacerbated Respiratory Disease
What is aspirin-exacerbated respiratory disease (AERD) Aspirin-exacerbated respiratory disease (AERD) is a clinical tetrad of nasal polyps, chronic hypertrophic eosinophilic sinusitis, asthma and sensitivity to any medication that inhibits cyclooxygenase-1 (COX-1) enzymes, namely aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs)…
Genetic Basis of Asthma
Asthma is the most common chronic childhood disease in developed nations and its prevalence has increased in the world over the last 25 years. It is a complex disease with both genetic and environmental risk factors. Asthma is caused by…
Learn About Biomarkers in Asthma and Why they Matter
Asthma is a heterogenous disease characterized by multiple phenotypes driven by different mechanisms. The implementation of precision medicine in the management of asthma requires the identification of phenotype-specific markers measurable in biological fluids. To become useful, these biomarkers need to…
Asthma’s Inner World – a patients journey of discovery
By Alan Gray World Asthma Foundation (WAF) is supporting care of Asthma and asthmatics around the world through a new Severe Asthma Series focused on “Defeating Asthma” with the aim of shining a spotlight on a deeper understanding and getting…